The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting

被引:34
作者
Barnard, Dewald A. [1 ,2 ]
Irusen, Elvis M. [1 ,2 ]
Bruwer, Johannes W. [1 ,2 ]
Plekker, Dante [3 ]
Whitelaw, Andrew C. [2 ,4 ,5 ]
Deetlefs, Jacobus D. [6 ]
Koegelenberg, Coenraad F. N. [1 ,2 ]
机构
[1] Univ Stellenbosch, Div Pulmonol, Dept Med, ZA-7505 Cape Town, South Africa
[2] Tygerberg Acad Hosp, Cape Town, South Africa
[3] Kuils River Hosp, Cape Town, South Africa
[4] Univ Stellenbosch, Dept Pathol, Div Med Microbiol & Immunol, ZA-7505 Cape Town, South Africa
[5] Natl Hlth Lab Serv, Cape Town, South Africa
[6] Ampath Labs, Cape Town, South Africa
来源
BMC PULMONARY MEDICINE | 2015年 / 15卷
关键词
FIBEROPTIC BRONCHOSCOPY; DIAGNOSTIC-ACCURACY; ASSAY; RESISTANCE; SPECIFICITY; BURDEN;
D O I
10.1186/s12890-015-0086-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Xpert MTB/RIF has been shown to have a superior sensitivity to microscopy for acid fast bacilli (AFB) in sputum and has been recommended as a standard first line investigation for pulmonary tuberculosis (PTB). Bronchoscopy is a valuable tool in diagnosing PTB in sputum negative patients. There is limited data on the utility of Xpert MTB/RIF performed on bronchial lavage specimens. Our aim was to evaluate the diagnostic efficiency of Xpert MTB/RIF performed on bronchial washings in sputum scarce/negative patients with suspected PTB. Methods: All patients with a clinical and radiological suspicion of PTB who underwent bronchoscopy between January 2013 and April 2014 were included. The diagnostic efficiencies of Xpert MTB/RIF and microscopy for AFB were compared to culture for Mycobacterium tuberculosis. Results: Thirty nine of 112 patients were diagnosed with culture-positive PTB. Xpert MTB/RIF was positive in 36/39 with a sensitivity of 92.3 % (95 % CI 78-98 %) for PTB, which was superior to that of smear microscopy (41 %; 95 % CI 26.0-57.8 %, p = 0.005). The specificities of Xpert MTB/RIF and smear microscopy were 87.7 % (95 % CI 77.4-93.9 %) and 98.6 % (95 % CI 91.6 %-99.9 %) respectively. Xpert MTB/RIF had a positive predictive value of 80 % (95 % CI; 65-89.9 %) and negative predictive value of 95.5 % (95 % CI 86.6-98.8 %). 3/9 patients with Xpert MTB/RIF positive culture negative results were treated for PTB based on clinical and radiological findings. Conclusion: Xpert MTB/RIF has a higher sensitivity than smear microscopy and similar specificity for the immediate confirmation of PTB in specimens obtained by bronchial washing, and should be utilised in patients with a high suspicion of pulmonary tuberculosis.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] [Anonymous], WHO Global Tuberculosis Programme
  • [2] Diagnosing sputum/smear-negative pulmonary tuberculosis: Does fibre-optic bronchoscopy play a significant role
    Bachh, Arshad Altaf
    Gupta, Rahul
    Haq, Inaamul
    Varudkar, Hanumant Ganapati
    [J]. LUNG INDIA, 2010, 27 (02) : 58 - 62
  • [3] Bactec, 2007, MGIT BACTEC MGIT 960
  • [4] Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay
    Blakemore, Robert
    Story, Elizabeth
    Helb, Danica
    Kop, JoAnn
    Banada, Padmapriya
    Owens, Michelle R.
    Chakravorty, Soumitesh
    Jones, Martin
    Alland, David
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (07) : 2495 - 2501
  • [5] Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
    Boehme, Catharina C.
    Nicol, Mark P.
    Nabeta, Pamela
    Michael, Joy S.
    Gotuzzo, Eduardo
    Tahirli, Rasim
    Gler, Ma Tarcela
    Blakemore, Robert
    Worodria, William
    Gray, Christen
    Huang, Laurence
    Caceres, Tatiana
    Mehdiyev, Rafail
    Raymond, Lawrence
    Whitelaw, Andrew
    Sagadevan, Kalaiselvan
    Alexander, Heather
    Albert, Heidi
    Cobelens, Frank
    Cox, Helen
    Alland, David
    Perkins, Mark D.
    [J]. LANCET, 2011, 377 (9776) : 1495 - 1505
  • [6] False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results
    Boyles, T. H.
    Hughes, J.
    Cox, V.
    Burton, R.
    Meintjes, G.
    Mendelson, M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (07) : 876 - 878
  • [7] Cepheid, 2010, XPERT MTB RIF BROCH, P1
  • [8] Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis
    Chang, Kai
    Lu, Weiping
    Wang, Junji
    Zhang, Kejun
    Jia, Shuangrong
    Li, Fake
    Deng, Shaoli
    Chen, Ming
    [J]. JOURNAL OF INFECTION, 2012, 64 (06) : 580 - 588
  • [9] Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
    Friedrich, Sven O.
    Rachow, Andrea
    Saathoff, Elmar
    Singh, Kasha
    Mangu, Chacha D.
    Dawson, Rodney
    Phillips, Patrick P. J.
    Venter, Amour
    Bateson, Anna
    Boehme, Catharina C.
    Heinrich, Norbert
    Hunt, Robert D.
    Boeree, Martin J.
    Zumla, Alimuddin
    McHugh, Timothy D.
    Gillespie, Stephen H.
    Diacon, Andreas H.
    Hoelscher, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2013, 1 (06) : 462 - 470
  • [10] Xpert MTB/RIF as a Measure of Sputum Bacillary Burden Variation by HIV Status and Immunosuppression
    Hanrahan, Colleen F.
    Theron, Grant
    Bassett, Jean
    Dheda, Keertan
    Scott, Lesley
    Stevens, Wendy
    Sanne, Ian
    Van Riel, Annelies
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (11) : 1426 - 1434